Ran Nie

Ran Nie

Auto-generated profile, based on publicly available information

Ran Nie

Department of Stomatology, The First Hospital of Jilin University, Jilin University , Changchun 130021

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
RNRan Nie
Ran Nie
YSYue Sun
Yue Sun
HLHuixin Lv
Huixin Lv
MLMing Lu
Ming Lu
HHHuimin Huangfu
Huimin Huangfu
YZYanmin Zhou
Yanmin Zhou
The design of bifunctional 3D printed scaffolds GelMA/β-TCP/sodium alginate (Sr2+)/MXene provides an effective strategy for the personalized treatment of infected bone defects and broadens the biomedical application of 2D nanomaterial MXenes.

13 December 2025 in Stem Cells
Verified
Journal Article
Closed access
HLHaiou Liu
Haiou Liu
RNRan Nie
Ran Nie
JJJinlan Jiang
Jinlan Jiang
CZCongxiao Zhang
Congxiao Zhang
Osteoradionecrosis of the jaws (ORNJ) is a severe aseptic complication of high-dose radiotherapy for head-and-neck cancers, characterized by chronic jawbone necrosis, functional impairment, and poor responses to traditional treatments (eg, hyperbaric oxygen and surgical resection) that fail to address its root pathophysiology (microcirculatory impairment, bone metabolism dysfunction). Its incidence is 1.2%-40% in patients receiving >60 Gy radiotherapy, especially with concurrent trauma. In recent years, stem cell therapy has garnered attention as a potential treatment for a variety of bone-related disorders, including the repair of bone defects, treatment of osteoarthritis, and mitigation of osteoporosis. Evidence from preclinical studies indicates that local transplantation of mesenchymal stem cells in rodent models of ORNJ significantly increases bone volume and bone mineral density. The therapeutic efficacy is primarily attributed to the cells’ capacity for multidirectional differentiation, paracrine signaling, and immunomodulatory functions, highlighting their substantial potential for clinical translation. This narrative review synthesizes studies on stem cell therapy for ORNJ published from 2004 to 2024 (PubMed, Medline, Cochrane), with a focus on original research published in the most recent decade (2014-2024) to reflect the latest advances. This review consolidates ORNJ pathogenesis and stem cell mechanisms, identifies research gaps, and guides future efforts to standardize protocols and advance clinical translation.